Provided by Tiger Trade Technology Pte. Ltd.

Merck

152.55
+3.562.39%
Pre-market: 153.621.07+0.70%04:11 EDT
Volume:15.98M
Turnover:2.44B
Market Cap:376.37B
PE:119.85
High:154.49
Open:149.12
Low:148.59
Close:148.99
52wk High:154.49
52wk Low:77.58
Shares:2.47B
Float Shares:2.47B
Volume Ratio:1.07
T/O Rate:0.65%
Dividend:3.32
Dividend Rate:2.18%
EPS(TTM):1.27
EPS(LYR):7.28
ROE:6.96%
ROA:11.87%
PB:8.98
PE(LYR):20.95

Loading ...

Merck Launches Early Access Initiative for Monthly Oral HIV Prevention Drug Alimatravir

Deep News
·
Jul 24

Aspen Pharmacare: Under Agreement, Co to Receive Technical Package from Msd, Together with Licensing Rights Covering 129 Countries

THOMSON REUTERS
·
Jul 24

Merck Outlines Access Plan for Investigational Monthly HIV Prevention Pill

MT Newswires Live
·
Jul 24

Gilead Sciences Says EMA Recommends Trodelvy-Keytruda Combination for Breast Cancer

MT Newswires Live
·
Jul 24

Merck announces initial access plans for alimatravir

TIPRANKS
·
Jul 24

Merck & Co - Signs Seven Voluntary Licensing Agreements with Generic Manufacturers in Africa and India

THOMSON REUTERS
·
Jul 24

Merck & Co - Royalty-free Agreements Enable Supply of Generic Alimatravir in 129 Lmics

THOMSON REUTERS
·
Jul 24

Merck Licenses Experimental HIV Pill to Generic Makers in 129 Countries

Reuters
·
Jul 24

Merck: Voluntary Licensing Agreements for Alimatravir Cover 129 Countries

THOMSON REUTERS
·
Jul 24

Merck: Plans Initial Alimatravir Supply Pending Regulatory Approval, Generic Manufacturing Ramp-up in Licensed Territories

THOMSON REUTERS
·
Jul 24

Merck: Announces Initial Access Plans for Alimatravir in Low- and Middle Income Countries for Prevention of Hiv-1

THOMSON REUTERS
·
Jul 24

Merck: in Active Discussions with Fiocruz on Alimatravir Availability in Latin America & Brazil

THOMSON REUTERS
·
Jul 24

Gilead’s Trodelvy plus Merck’s Keytruda recommended by CHMP in breast cancer

TIPRANKS
·
Jul 24

Merck & Co. Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24

Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers

MT Newswires Live
·
Jul 23

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Trade Options When Others are Fearful

Dow Jones
·
Jul 22

Gilead, Merck Weekly HIV Pill Keeps Virus Suppressed in Late-stage Trials

Reuters
·
Jul 22

Merck Posts Press Release on Once-weekly Oral HIV Regimen Trial Results

Reuters
·
Jul 21

Phanes Therapeutics: to Evaluate Spevatamig in Combination with Keytruda & Chemotherapy for Treatment of Biliary Tract Cancer

THOMSON REUTERS
·
Jul 21